Pre-Print Servers

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 22 Jan 2022]

[No new digest content identified]

medRxiv
https://www.medrxiv.org/content/about-medrxiv
medRxiv is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. medRxiv is for the distribution of preprints – complete but unpublished manuscripts – that describe human health research conducted, analyzed, and interpreted according to scientific principles…
January 22, 2022 – No digest content identified

January 21, 2022
A booster dose of mRNA-based COVID-19 vaccines fosters the development of an immune response in immunosuppressed fragile patients.
Elena Azzolini, Chiara Pozzi, Luca Germagnoli, Bianca Oresta, Nicola Carriglio, Mariella Calleri, Carlo Selmi, Maria De Santis, Silvia Finazzi, Carmelo Carlo-Stella, Alexia Bertuzzi, Francesca Motta, Angela Ceribelli, Alberto Mantovani, Fabrizio Bonelli, Maria Rescigno
medRxiv 2022.01.21.22269633; doi: https://doi.org/10.1101/2022.01.21.22269633

The Global case-fatality rate of COVID-19 has been declining disproportionately between top vaccinated countries and the rest of the world
Najmul Haider, Mohammad Nayeem Hasan, Rumi Ahmed Khan, David McCoy, Francine Ntoumi, Osman Dar, Rashid Ansumana, Md. Jamal Uddin, Alimuddin Zumla, Richard A Kock
medRxiv 2022.01.19.22269493; doi: https://doi.org/10.1101/2022.01.19.22269493

Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan
Wajiha Rizwan, Ahmad Uzair Qureshi, Muhammad Nasir Rana, Mubeen Nazar Duggal, Muhammad Sohaib, Masood Sadiq
medRxiv 2022.01.18.22268965; doi: https://doi.org/10.1101/2022.01.18.22268965

mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients
Maria Teresa Lupo Stanghellini, Serena Di Cosimo, Massimo Costantini, Sara Monti, Renato Mantegazza, Alberto Mantovani, Carlo Salvarani, Pier Luigi Zinzani, Matilde Inglese, Fabio Ciceri, Giovanni Apolone, Gennaro Ciliberto, Fausto Baldanti, Aldo Morrone, Valentina Sinno, Franco Locatelli, Stefania Notari, Elena Turola, Diana Giannarelli, Nicola Silvestris
medRxiv 2022.01.18.22269351; doi: https://doi.org/10.1101/2022.01.18.22269351

One vaccine to counter many diseases? Modelling the economics of oral polio vaccine against child mortality and COVID-19
Angela Y Chang, Peter Aaby, Michael S Avidan, Christine S Benn, Stefano M Bertozzi, Lawrence Blatt, Konstantin Chumakov, Shabaana A Khader, Shyam Kottilil, Madhav Nekkar, Mihai G Netea, Annie Sparrow, Dean T Jamison
medRxiv 2022.01.19.22269560; doi: https://doi.org/10.1101/2022.01.19.22269560

Wellcome Open Research [to 22 Jan 2022]
https://wellcomeopenresearch.org/browse/articles
[Accessed 22 Jan 2022]

Wellcome Open Research provides all Wellcome researchers with a place to rapidly publish any results they think are worth sharing. All articles benefit from rapid publication, transparent peer review and editorial guidance on making all source data openly available.
Research Article metrics
Revised
An agency mapping of marginalized communities and aid providers during the COVID-19 pandemic in Malaysia [version 2; peer review: 1 approved]
Melati Nungsari, Chuah Hui Yin, Nicole Fong, Veena Pillai
Peer Reviewer Zinette Bergman
Funder – World Health Organization
LATEST VERSION PUBLISHED 20 Jan 2022